Media

Support Of Industry Underscores Pro-Business Commitment
Commercialization of cleaner, safer consumer products through innovative industrial biotechnology processes will be the focus of breakout sessions at the...

Press Releases

Nov 22 1999
WASHINGTON, D.C. (Nov. 22, 1999) -- Included in the 2000 budget legislation passed by Congress are three measures that give a major boost to the biotechnology...
Nov 18 1999
The Biotechnology Industry Organization (BIO) is pleased to be invited by the Food and Drug Administration (FDA) to participate on the Food Safety Panel for...
Nov 18 1999
Thank you for inviting the Biotechnology Industry Organization (BIO) to provide a statement on the Food and Drug Administration's policy on information issues...
Nov 16 1999
WASHINGTON, D.C. (Nov. 16, 1999) -- The Biotechnology Industry Organization (BIO) fully concurs with the U.S. Food and Drug Administration's (FDA) initiative...
Nov 16 1999
WASHINGTON, D.C. -- (Carl B. Feldbaum, president of the Biotechnology Industry Organization, issued the following statement in advance of the Food and Drug...
Nov 10 1999
(Michael J. Phillips, Ph.D, Executive Director for Food & Agriculture, issued the following statement in response to Congressman Kucinich's legislation...
Nov 2 1999
Nov. 2, 1999 (Chicago) -- Genetically improved corn poses negligible harm to the Monarch butterfly population, a panel of scientists is expected to conclude at...
Oct 22 1999
WASHINGTON, D.C. (Oct. 22, 1999) -- The BiotechnologyIndustry Organization will host its second annual CEO & Investor Conference, ô2000 Reasons to Invest...
Oct 14 1999
October 14, 1999 Mr. Arthur O. Sulzberger, Jr.PublisherNew York Times229 West 43rd Street New York, NY 10036 Dear Mr. Sulzberger: On October 11, the New York...


Biotechnology News

September 20, 2014

MONT-TREMBLANT, Quebec--(BUSINESS WIRE)--FibroGen, Inc. (FibroGen) announced today the presentation of the full data set from a clinical study of patients with idiopathic...

September 19, 2014

LOS ANGELES--(BUSINESS WIRE)--Contact Glancy Binkow & Goldberg LLP if you purchased PDL BioPharma, Inc. securities between November 6, 2013 and September 16, 2014.

September 19, 2014

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, today announced that management will present a...

September 19, 2014

PASADENA, Calif.--(BUSINESS WIRE)--Arrowhead Research will present at BioCentury’s 21st Annual NewsMakers in the Biotech Industry conference on September 26, 2014 at 10:30...

September 19, 2014

PARIS & COPENHAGEN, Denmark--(BUSINESS WIRE)--Regulatory News: Onxeo SA (Paris:ONXEO) (NASDAQ OMX:ONXEO) (Euronext Paris, NASDAQ OMX Copenhagen - ONXEO), an innovative...